Cluster Headache — Acute & Preventive Treatment

Key Points

• Cluster headache causes excruciating unilateral orbital, supraorbital, or temporal pain lasting 15-180 minutes with ipsilateral autonomic features such as lacrimation, conjunctival injection, nasal congestion, rhinorrhea, ptosis, or miosis.
• Diagnosis is clinical when the pattern is typical, but MRI brain with attention to the pituitary/cavernous-sinus region is appropriate for atypical features, abnormal neurologic examination, or a new cluster-like syndrome.
• Treat acute attacks immediately with 100% oxygen delivered through a nonrebreather mask at high flow, commonly 12-15 L/min or higher as needed, and/or subcutaneous sumatriptan 6 mg.
• Use Clinical headache pattern and other targeted evaluation to answer specific diagnostic or safety questions rather than ordering broad testing without a plan.
• Escalate urgently for first or atypical cluster-like headache with focal deficit, Horner syndrome outside attacks, fever, or persistent neurologic findings.
• Other major warning findings include suicidal ideation or severe behavioral distress related to extreme pain and cardiac conduction abnormality during verapamil titration or contraindication to triptan therapy.
• Medication and procedural choices should be matched to physiology, contraindications, renal/hepatic function, pregnancy status, and interaction risk when relevant.
• Provide a written plan for rapid oxygen access and rescue medication because attacks peak quickly.

Algorithm

1. Confirm that the presentation is consistent with Cluster Headache — Acute & Preventive Treatment and identify immediately life-threatening alternatives or complications.
2. Obtain a focused history and examination that define severity, mechanism, relevant comorbidity, prior treatment, and baseline function.
3. Use targeted evaluation such as Clinical headache pattern, Neurologic examination, and other tests only when they can change management.
4. Classify the patient into a treatment pathway based on stability, disease/procedure subtype, organ function, and the presence or absence of escalation findings.
5. Begin the first-line intervention described for Cluster Headache — Acute & Preventive Treatment, using the least complex safe regimen that directly treats the mechanism.
6. Reassess symptoms, vital signs, examination, laboratory or imaging response, and treatment toxicity after the first clinically meaningful interval.
7. Stop routine progression and escalate care for first or atypical cluster-like headache with focal deficit, Horner syndrome outside attacks, fever, or persistent neurologic findings, suicidal ideation or severe behavioral distress related to extreme pain, or cardiac conduction abnormality during verapamil titration or contraindication to triptan therapy.
8. At discharge or transition, document the final diagnosis, remaining uncertainty, medication/procedure plan, follow-up timing, prevention strategy, and explicit return precautions.

Clinical Synopsis & Reasoning

Cluster headache causes excruciating unilateral orbital, supraorbital, or temporal pain lasting 15-180 minutes with ipsilateral autonomic features such as lacrimation, conjunctival injection, nasal congestion, rhinorrhea, ptosis, or miosis. Patients are often restless or agitated during attacks, contrasting with the desire to lie still that is common in migraine.

Diagnosis is clinical when the pattern is typical, but MRI brain with attention to the pituitary/cavernous-sinus region is appropriate for atypical features, abnormal neurologic examination, or a new cluster-like syndrome. Ask about attack timing, alcohol as a bout trigger, sleep, smoking, and medication history. Check blood pressure and ECG before high-dose verapamil escalation.

The practical diagnostic task is to decide what must be established immediately, what can be clarified after stabilization, and which finding would change the working diagnosis. Useful evaluation elements include Clinical headache pattern, Neurologic examination, MRI brain when atypical/new, ECG. Each test should answer a defined question rather than be ordered reflexively. Serial examination is especially important when early results can be normal or when treatment itself changes the physiology being measured.

Neurologic disorders often require careful attention to tempo, distribution, and positive examination findings because the same symptom can arise from very different anatomic mechanisms. For Cluster Headache — Acute & Preventive Treatment, the clinician should explicitly separate expected findings from escalation findings such as first or atypical cluster-like headache with focal deficit, Horner syndrome outside attacks, fever, or persistent neurologic findings, suicidal ideation or severe behavioral distress related to extreme pain, or cardiac conduction abnormality during verapamil titration or contraindication to triptan therapy.

Treatment Strategy & Disposition

Treat acute attacks immediately with 100% oxygen delivered through a nonrebreather mask at high flow, commonly 12-15 L/min or higher as needed, and/or subcutaneous sumatriptan 6 mg. Intranasal triptans can help when injection is not possible but are slower. Verapamil is a common first-line preventive during a cluster bout and requires ECG monitoring with dose escalation. A short prednisone taper or greater occipital nerve block can bridge the delay before preventive benefit. Refractory disease warrants headache-specialist care.

Provide a written plan for rapid oxygen access and rescue medication because attacks peak quickly. Reassess bout duration, attack frequency, ECG, and preventive need; episodic preventive therapy can often be tapered after a sustained attack-free interval.

Treatment should be reassessed after the first meaningful intervention rather than allowed to continue automatically. Relevant medications or therapeutic agents in this topic include 100% oxygen, Sumatriptan 6 mg SC, Verapamil, Prednisone. Their usefulness depends on the indication, patient physiology, and contraindications shown in the sections below. If the response is poorer than expected, revisit the diagnosis, treatment delivery, adherence or access, procedure success when relevant, and the possibility of a complication.

Emergency red flags should be separated from chronic disability management: stabilization and exclusion of time-sensitive structural disease come first, followed by mechanism-specific treatment and rehabilitation. Functional outcomes, cognition, mobility, sleep, mood, and caregiver burden are important longitudinal endpoints in addition to examination findings.

Epidemiology / Risk Factors

• Cluster Headache — Acute & Preventive Treatment is a neurologic topic where tempo and examination pattern help distinguish common disease from time-sensitive mimics.
• Disability can persist even after the acute mechanism is treated, making rehabilitation, symptom management, and functional follow-up important parts of care.
• Delayed diagnosis is most harmful when a rapidly progressive, structural, vascular, infectious, or respiratory-threatening process is mistaken for a routine chronic syndrome.

Investigations

Cluster Headache Treatment Timing

Pharmacology

Prognosis / Complications

• Outcome in Cluster Headache — Acute & Preventive Treatment depends on baseline severity, underlying mechanism, comorbidity, speed of appropriate treatment, and whether major complications develop.
• Patients who respond as expected still need follow-up focused on recurrence prevention, treatment adverse effects, and restoration of function or physiologic stability.
• The appearance of first or atypical cluster-like headache with focal deficit, Horner syndrome outside attacks, fever, or persistent neurologic findings or suicidal ideation or severe behavioral distress related to extreme pain changes prognosis and should prompt a higher-acuity reassessment rather than routine outpatient progression.
• A durable plan is one that the patient can follow outside the clinical setting and that includes clear thresholds for returning to care.

Patient Education / Counseling

• Explain the diagnosis of Cluster Headache — Acute & Preventive Treatment in plain language, including what is known, what remains uncertain, and what the immediate treatment is intended to accomplish.
• Review how the patient should take or use the recommended therapy and what common adverse effects or practical barriers to expect.
• Explain that worsening symptoms are not always a normal part of recovery and give specific return precautions for first or atypical cluster-like headache with focal deficit, Horner syndrome outside attacks, fever, or persistent neurologic findings.
• Also seek prompt care for suicidal ideation or severe behavioral distress related to extreme pain or cardiac conduction abnormality during verapamil titration or contraindication to triptan therapy.
• Discuss prevention or risk reduction relevant to the condition, including medication adherence, follow-up testing, rehabilitation, vaccination, sexual/partner management, or lifestyle factors as appropriate.
• Use teach-back at discharge so the patient or caregiver can state the treatment plan, follow-up timing, and reasons to return.

Notes

The main practical error in Cluster Headache — Acute & Preventive Treatment is to reduce the topic to a memorized list without linking each action to a clinical purpose. A safer approach identifies the decision point, chooses the test or intervention that changes that decision, and then reassesses whether the patient is moving in the expected direction. Findings such as first or atypical cluster-like headache with focal deficit, Horner syndrome outside attacks, fever, or persistent neurologic findings, suicidal ideation or severe behavioral distress related to extreme pain, and cardiac conduction abnormality during verapamil titration or contraindication to triptan therapy should move the patient out of a routine pathway and into higher-acuity diagnostic or specialty assessment.

Documentation should make the reasoning reproducible. Record the baseline state, the key evidence supporting the diagnosis, major alternatives that were addressed, treatment actually delivered, response, and the follow-up responsibility. This is particularly important when multiple clinicians will share care or when a procedure, high-risk medication, evolving laboratory abnormality, or time-sensitive infection/vascular syndrome is involved. Once the patient is stable, the remaining work is prevention: address modifiable risk, treatment access, adherence, functional recovery, and the specific complication most likely to cause return to care.

References

1. American Headache Society - Cluster Headache Resources — Link
2. American Academy of Neurology - Clinical Practice Guidelines — Link
3. American Heart Association/American Stroke Association - Guidelines — Link